Azelastine ophthalmic and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Azelastine ophthalmic and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: azelastine ophthalmic
Brand name: Optivar
Synonyms: Azelastine (Ophthalmic)
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Azelastine ophthalmic-Insulin degludec
- Azelastine ophthalmic-Insulin Degludec (U-100) Prefilled Pens
- Azelastine ophthalmic-Insulin Degludec (U-100) Vials
- Azelastine ophthalmic-Insulin Degludec (U-200) Prefilled Pens
- Azelastine ophthalmic-Insulin degludec and liraglutide
- Azelastine ophthalmic-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Azelastine Ophthalmic Solution
- Insulin aspart, recombinant Subcutaneous-Azelex
- Insulin aspart, recombinant Subcutaneous-Azelex Topical
- Insulin aspart, recombinant Subcutaneous-Azesco
- Insulin aspart, recombinant Subcutaneous-Azilect
- Insulin aspart, recombinant Subcutaneous-Azilsartan